Monday, 26 October 20262:02 am ISTIndia edition

सच, सीधे आप तक

Book ad space

Just in

Health

This drug combo cuts death-risk in cancer cases by 58%

Image: Newsbytes. Rights remain with the publisher.

Amgen's Imdelltra, an immunotherapy drug, has been found to significantly increase survival rates in patients with aggressive small cell lung cancer (SCLC) when used with AstraZeneca's Imfinzi.

Read the full report on Newsbytes

Story file

Section
Health
Topics
Health alerts
First reported by
Newsbytes
Reporter
dwaipayan roy
Published
Sunday, 25 October 2026, 11:37 am IST
Coverage
One outlet so far

How this page works. The Headline Update lists this report from Newsbytes with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.

Related stories

More Health news

See all